Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: An analysis of patient data from a Maryland-based health maintenance organization
References (38)
- et al.
Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry)
Am J Cardiol
(1996) - et al.
Comparison of oneyear outcome in women versus men with chronic congestive heart failure
Am J Cardiol
(2000) - et al.
Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population
Am Heart J
(1986) Perceived gender bias in the treatment of cardiovascular disease
J Vasc Nurs
(1997)- et al.
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
Am J Cardiol
(1998) - et al.
Utilization of lipid-lowering drugs in men and women. A reflection of the research evidence?
J Clin Epidemiol
(2002) - et al.
Treatment patterns and distribution of low-density lipoprotein choles terol levels in treatment-eligible United States adults
Am J Cardiol
(1998) - et al.
Task Force #4-adherence issues and behavior changes: Achieving a long-term solution
- et al.
How should we treat hypertensive women with cardiac and renal impairment?
Am J Hypertens
(1997) - et al.
Heart Disease and Stroke Statistics—2006 Update. A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation
(2006)
Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry
Arch Intern Med
Do women with acute myocardial infarction receive the same treatment as men?
BMJ
Gender differences in the presentation, treatment, and short-term mortality of acute chest pain
Clin Invest Med
Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants
N Engl J Med
Management of congestive heart failure: A gender gap may still exist. Observations from a contemporary cohort
BMC Cardiovasc Disord
Is there a clinically significant gender bias in post-myocardial infarction pharmacological management in the older (>60) population of a primary care practice?
BMC Fam Pract
Sex inequalities in ischaemic heart disease in general practice: Cross-sectional survey
BMJ
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
Circulation
Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
JAMA
Cited by (25)
The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland
2018, AtherosclerosisCitation Excerpt :Then, the FH prevalence was calculated as weighted mean, 3.3%. The probability of hLDL in non-FH, ACS patients is increased; we assumed 87.14% (based on the probability of hLDL in ACS patients [40]). The risk of falsely attributing hLDL to other-than-FH causes in (undiagnosed) truly FH patients was estimated to 20% (experts' opinion).
Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States
2016, Journal of Clinical LipidologyCitation Excerpt :Patients with established CHD and CHD risk equivalent (CHD RE) indications have a high risk of subsequent CV events including myocardial infarction (MI), stroke, and death, and statins have been recommended as the first choice of treatment in these patients to reduce CVD events.9 However, statins also have their challenges with several studies indicating suboptimal use in high-risk patients,10–14 elevated LDL-C levels in spite of statin use,15 and the issue of residual CVD risk in patients even with high-intensity statin treatment.16–19 The National Cholesterol Education Program Adult Treatment Panel III (ATP III) guidelines considered patients with CHD or a CHD RE diagnosis to be high-risk patients and recommended an LDL-C goal of <100 mg/dL.20
Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia
2014, Journal of the American College of CardiologyGender difference in statin intervention on blood lipid control among patients with coronary heart disease
2013, International Journal of GerontologyCitation Excerpt :In the Maryland-based health maintenance organization study, there was no difference between the proportion of men (71.4%) and women (63.3%) prescribed lipid-lowering therapy. As a result, more men (51.0%) than women (36.7%) reached the LDL-C of <2.59 mmol/L (<100 mg/dL)18. A report from China showed that in patients with high cardiovascular risk, the rate of statin therapy was much higher (82.2%); however, the LDL-C attainment (<2.6 mmol/L, 100 mg/dL) rate was relatively lower in men (45.5%) and women (28.5%)15.
Hyperlipidemia in patients with schizophrenia: A national population-based study
2012, General Hospital PsychiatryCitation Excerpt :Of interest, the incidence rate of hyperlipidemia for women is much greater that of men after age of 50 years, which was in accordance with other surveys about metabolic problems [6,27]. Hormones, such as estrogen, protect women from the development of risk factors for CHD not only in the general population [32,33] but also in schizophrenic patients [8,13]. After menopause, the hyperprolactinemia status and change of gonadal hormone levels are much more obvious for women and make them vulnerable to having poor lipid profiles [34].
Attainment of low-density lipoprotein cholesterol goals in coronary artery disease
2010, Journal of Clinical Lipidology